Role
CEO and Founder of Invetx with the vision for Invetx to become the leading veterinary biotherapeutics company.

Experience
15+ years in various leadership roles in Marketing and R&D in the Animal Health industry and biotech. New product development for global markets with a focus to transfer and apply innovative technologies from human biotechnology to advance veterinary medicine.

Previous
Novartis Animal Health, Novartis Institute for Biomedical Research, Elanco/Lilly, Nexvet

Education
Dr. med. vet., Ludwig Maximilians University Munich, Germany
PhD, Royal Veterinary College, University of London, UK
EMBA, London Business School, UK & Columbia Business School, NYC, US

Role
Clinical and Regulatory Affairs, passionate about bringing Invetx’s portfolio of innovative veterinary biotherapeutics through the regulatory process to be available to practicing veterinarians and their patients.

Experience
35 years of experience in the management of R&D in the Animal Health Industry including many years in senior leadership positions; focused on bringing innovative veterinary medicines to the marketplace.

Previous
Pfizer Animal Health (now Zoetis), Nexvet Biopharma, Independent Consultant

Education
BVetMed, Royal Veterinary College, University of London, UK
PhD, Royal Veterinary College, University of London, UK

Role
Develop and execute a research strategy to generate innovative and transformative biotherapeutics for the Animal Health market.

Experience
20+ years of experience in developing protein therapeutics for oncology indications, immune-mediated diseases, infectious diseases, rare diseases and reproductive health and contraception.

Previous
Ohana Biosciences, Sanofi, Genzyme and Serono

Education
PhD in Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison

Role
Oversee and manage the finances and accounting to ensure timely, accurate and complete corporate reporting for the leadership team and investors. Inside legal counsel.

Experience
15+ years as CFO for a variety of life science and technology companies from start-up through profitability. Financial leader through many successful corporate transactions.

Previous
X-Chem, X-Body, Psy Therapeutics. Served as CFO to a broad client base with a concentration in life sciences through financial advisory firms.

Education
JD/LLM, Suffolk University Law School
MBA, Babson College
BBA Accounting, University of Massachusetts at Amherst

Role
CMC development, manufacturing, quality and regulatory. Build and implement development and manufacturing strategies to bring Invetx’s transformative biotherapeutics programs to the animal health market.

Experience
20+ years of technical and leadership experience in biologics CMC development and manufacturing of novel biologics and biosimilars including cytokines, monoclonal antibodies, bispecifics, antibody drug conjugates, peptibodies, and Fc fusion proteins.
Supported 20+ IND stage programs, multiple BLA regulatory filings and successful approvals of human biotherapeutics products.

Previous
MacroGenics, NexImmune, Hospira/Pfizer and Amgen

Education
PhD, Pharmaceutical Sciences, University of Colorado Health Sciences Center, Denver, US
BS Pharmacy, Chennai Medical College, Chennai, India
Lean Six Sigma Green Belt

Role
Clinical and Regulatory Affairs, dedicated to developing Invetx’s portfolio of innovative veterinary biotherapeutics while defining global regulatory registration strategies and leading global clinical trials generating clinical evidence to obtain regulatory approvals.

Experience
25 years of R&D management experience in the Animal Health and Human Pharma Industries including senior leadership roles; focused on bringing innovative veterinary and human pharma medicines to the market.

Previous
Schering-Plough (now Merck), Bayer Animal Health, Elanco

Education
DVM, Lithuanian University of Health Sciences, Kaunas, Lithuania
MBA, Indiana State University, Terre Haute, IN
MBA in Pharmaceutical Management, Fairleigh Dickinson University, Teaneck, NJ

Role
Oversee and direct discovery, characterization and developability of transformative biotherapeutics for the Animal Health Market.

Experience
10+ years of experience in discovery and bioanalytics of protein therapeutics for rare disease, oncology, and infectious disease.  Expertise in protein expression, purification, and multi-specific targeting.

Previous
Sanofi, MassBiologics

Education
PhD in Genetics, GSBS, Tufts University
BS in Molecular and Cell Biology, University of Connecticut